Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

Summary

The purpose of this study is to determine if RTB101 prevents illness associated with respiratory tract infections in people ≥65 years of age.

Timeline

Start

2019-10-21

Primary completion

2019-11-15

Completion

2019-11-15

Outcome

Outcome not reported

Stopped: “Phase 3 trial RTB-101-204 study did not meet its primary endpoint”

Publications

• Background Mannick JB, Morris M, Hockey HP, Roma G, Beibel M, Kulmatycki K, Watkins M, Shavlakadze T, Zhou W, Quinn D, Glass DJ, Klickstein LB. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018 Jul 11;10(449):eaaq1564. doi: 10.1126/scitranslmed.aaq1564.

Drugs

Indications